ADVANCED HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2013/059246/06)
(“the Company” or “Advanced Health”)
ISIN Code: ZAE000189049 JSE Code: AVL
In terms of paragraph 3.4(b)(i) of the Listings Requirements of the JSE Limited, listed companies are required
to publish a trading statement as soon as they become reasonably certain that the financial results for the
next period to be reported on will differ by more than 20% from those of the previous corresponding period.
The directors of Advanced Health hereby advise shareholders that, in respect of the unaudited consolidated
interim results for the period ended 31 December 2020, the loss per share and headline loss per share are
expected to be as follows: –
Loss per share of 2.90 cents and headline loss per share of 2.16 cents for the period ended 31 December
2020 compared to a loss per share of 7.47 cents and headline loss per share of 6.92 cents for the comparative
period ended 31 December 2019 (this equates to a 61% decrease in the loss per share and a 69% decline in
headline loss per share).
The information in this trading statement has not been reviewed and reported on by the Company’s auditors.
Prior year figures were adjusted for discontinued operations.
23 February 2021
Grindrod Bank Limited
Date: 23-02-2021 05:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (‘JSE’).
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.